← FDA Drug Approvals (Drugs@FDA)

BANZEL

NDA · New Drug Application · Sponsor: EISAI INC · Approved 2011-03-03

Drug application

FDA Application #

NDA201367

Application type

New Drug Application

Brand name

BANZEL

Generic name

RUFINAMIDE

Active ingredients

RUFINAMIDE

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

EISAI INC

Manufacturer

Eisai Inc.

First approval

2011-03-03

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown